Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Biology and Environment (13)
- Clean Energy (27)
- Fusion and Fission (15)
- Fusion Energy (5)
- Isotopes (2)
- Materials (23)
- Materials for Computing (5)
- National Security (9)
- Neutron Science (10)
- Nuclear Science and Technology (8)
- Quantum information Science (2)
- Supercomputing (26)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.